New First-Line Option for Highly Mutated CRC? – Gastroenterology & Endoscopy News

New Haven, Conn, who was not involved with the study. The CheckMate 8HW trial enrolled patients 18 years of age and older with MSI-H/dMMR …

Do you trust this headline?

Based on recent headline ratings, 100% of this readership currently trusts the local media, which has an average score of 70% regionally and is currently trending positive.

100%

Media Trust Score100%